Saigopalakrishna S. Yerneni

Saigopalakrishna S. Yerneni

Auto-generated profile, based on publicly available information

Saigopalakrishna S. Yerneni

Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2019 in Science
Verified
Journal Article
Closed access
PDF file
ALA. Lee
A. Lee
AHA. R. Hudson
A. R. Hudson
DSDaniel J. Shiwarski
Daniel J. Shiwarski
JTJ. W. Tashman
J. W. Tashman
THT. J. Hinton
T. J. Hinton
AFAdam Walter Feinberg
Adam Walter Feinberg
If I only had a heart: 3D bioprinting is still a fairly new technique that has been limited in terms of resolution and by the materials that can be printed. Lee et al. describe a 3D printing technique to build complex collagen scaffolds for engineering biological tissues (see the Perspective by Dasgupta and Black). Collagen gelation was controlled by modulation of pH and could provide up to 10-micrometer resolution on printing. Cells could be embedded in the collagen or pores could be introduced into the scaffold via embedding of gelatin spheres. The authors demonstrated successful 3D printing of five components of the human heart spanning capillary to full-organ scale, which they validated for tissue and organ function. Science , this issue p. 482 ; see also p. 446

31 December 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SLSushil Lathwal
Sushil Lathwal
SYSaigopalakrishna S. Yerneni
Saigopalakrishna S. Yerneni
SBSusanne Boye
Susanne Boye
UMUpenyu Muza
Upenyu Muza
STShuntaro Takahashi
Shuntaro Takahashi
Krzysztof MatyjaszewskiKrzysztof Matyjaszewski
Krzysztof Matyjaszewski
Exosomes are emerging as ideal drug delivery vehicles due to their biological origin and ability to transfer cargo between cells. However, rapid clearance of exogenous exosomes from the circulation as well as aggregation of exosomes and shedding of surface proteins during storage limit their clinical translation. Here, we demonstrate highly controlled and reversible functionalization of exosome surfaces with well-defined polymers that modulate the exosome’s physiochemical and pharmacokinetic properties. Using cholesterol-modified DNA tethers and complementary DNA block copolymers, exosome surfaces were engineered with different biocompatible polymers. Additionally, polymers were directly grafted from the exosome surface using biocompatible photo-mediated atom transfer radical polymerization (ATRP). These exosome polymer hybrids (EPHs) exhibited enhanced stability under various storage conditions and in the presence of proteolytic enzymes. Tuning of the polymer length and surface loading allowed precise control over exosome surface interactions, cellular uptake, and preserved bioactivity. EPHs show fourfold higher blood circulation time without altering tissue distribution profiles. Our results highlight the potential of precise nanoengineering of exosomes toward developing advanced drug and therapeutic delivery systems using modern ATRP methods.

1 February 2022 in Biomaterials
Verified
Journal Article
Open access
YXYunhui Xing
Yunhui Xing
SYSaigopalakrishna S. Yerneni
Saigopalakrishna S. Yerneni
WWWeitao Wang
Weitao Wang
RTRebecca E. Taylor
Rebecca E. Taylor
PCPhil G. Campbell
Phil G. Campbell
XRXi Ren
Xi Ren
Nanoscale extracellular vesicles (EVs) represent a unique cellular derivative that reflect the therapeutic potential of mesenchymal stem cells (MSCs) toward tissue engineering and injury repair without the logistical and safety concerns of utilizing living cells. However, upon systemic administration in vivo,EVs undergo rapid clearance and typically lack controlled targeted delivery, thus reducing their effectiveness in therapeutic regenerative therapies. Here, we describe a strategy that enables long-term in vivo spatial EV retention by chemoselective immobilization of metabolically incoporated azido ligand-bearing EVs (azido-EVs) within a dibenzocyclooctyne-modified collagen hydrogel. MSC-derived azido-EVs exhibit comparable morphological and functional properties as their non-labeled EV counterparts and, when immobilized within collagen hydrogel implants via click chemistry, they elicited more robust host cell infiltration, angiogenic and immunoregulatory responses including vascular ingrowth and macrophage recruitment compared to ten times the higher dose required by non-immobilized EVs. We envision this technology will enable a wide range of applications to spatially promote vascularization and host integration relevant to tissue engineering and regenerative medicine applications.

4 March 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
NCNamit Chaudhary
Namit Chaudhary
ANAlexandra N. Newby
Alexandra N. Newby
MAMariah L. Arral
Mariah L. Arral
SYSaigopalakrishna S. Yerneni
Saigopalakrishna S. Yerneni
SLSamuel T. LoPresti
Samuel T. LoPresti
KWKathryn Whitehead
Kathryn Whitehead
Treating pregnancy-related disorders is exceptionally challenging because the threat of maternal and/or fetal toxicity discourages the use of existing medications and hinders new drug development. One potential solution is the use of lipid nanoparticle (LNP) RNA therapies, given their proven efficacy, tolerability, and lack of fetal accumulation. Here, we describe LNPs for efficacious mRNA delivery to maternal organs in pregnant mice via several routes of administration. In the placenta, our lead LNP transfected trophoblasts, endothelial cells, and immune cells, with efficacy being structurally dependent on the ionizable lipid polyamine headgroup. Next, we show that LNP-induced maternal inflammatory responses affect mRNA expression in the maternal compartment and hinder neonatal development. Specifically, pro-inflammatory LNP structures and routes of administration curtailed efficacy in maternal lymphoid organs in an IL-1β-dependent manner. Further, immunogenic LNPs provoked the infiltration of adaptive immune cells into the placenta and restricted pup growth after birth. Together, our results provide mechanism-based structural guidance on the design of potent LNPs for safe use during pregnancy.

30 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SASurya D. Aggarwal
Surya D. Aggarwal
ALAdrian J. Lloyd
Adrian J. Lloyd
SYSaigopalakrishna S. Yerneni
Saigopalakrishna S. Yerneni
ANAna Rita Narciso
Ana Rita Narciso
JSJennifer Shepherd
Jennifer Shepherd
NHN.Luisa Hiller
N.Luisa Hiller
Significance: During infection, microbes must survive the hostile environmental conditions of the human host. When exposed to stresses, bacteria activate an intracellular response, known as the stringent response pathway, to ensure their survival. This study connects two fundamental pathways important for cellular growth in a Gram-positive pathogen: it demonstrates that enzymes responsible for cell wall biosynthesis are connected to the stringent response pathway via their ability to ameliorate errors in protein translation. Our study was performed onS. pneumoniae, where the MurM cell wall biosynthesis enzyme, a tRNA-dependent amino acyl transferase, is linked to penicillin resistance. We now demonstrate the importance of MurM in translation quality control and establish that it serves as a gatekeeper of the stringent response pathway.

8 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMaria A. Stang
Maria A. Stang
ALAndrew Lee
Andrew Lee
JBJacqueline M. Bliley
Jacqueline M. Bliley
BCBrian D. Coffin
Brian D. Coffin
SYSaigopalakrishna S. Yerneni
Saigopalakrishna S. Yerneni
AFAdam Walter Feinberg
Adam Walter Feinberg
The hierarchical architecture of skeletal muscle spans from microscale sarcomeres to macroscale myofibers and is integral to its contractile functionality. Pathologies such as volumetric muscle loss (VML) compromise this structure and destroy the native extracellular matrix (ECM), exceeding the regenerative capacity of endogenous repair mechanisms. Here, we present a novel method for tissue engineering biomimetic three-dimensional (3D) skeletal muscle with complex architectures by leveraging freeform reversible embedding of suspended hydrogels (FRESH) 3D bioprinting of the ECM. Collagen type I scaffolds mimicking diverse muscle architectures— including parallel, unipennate, bipennate, multipennate, and convergent—were designed, FRESH printed, and seeded with C2C12 myoblasts to guide myogenesis. Engineered muscle tissues demonstrated scaffold-mediated alignment and fusion into functional myotubes, exhibiting contractile responses to electrical stimulation with architecture-dependent specific force of ∼1 kN/m 2 and a positive force-frequency relationship. In vivo implantation further revealed scaffold-directed cellular and vascular organization, underscoring the translational potential of this approach. In summary, this study demonstrates the capability to use FRESH 3D bioprinting to engineer physiologically relevant muscle architectures, significantly advancing the design of functional muscle tissues for regenerative medicine and in vitro modeling applications.